Made Scientific Selected as Manufacturer for Columbia University's Autologous and Allogeneic NOVAKnee Program - a First-in-Class Living Biologic Total Knee Replacement
Collaboration Supports ARPA-H-Funded Program to Develop Stem Cell Therapy Implants for Phase I Clinical Trial Under FDA Oversight PRINCETON, N.J., June 1, 2026 /PRNewswire/ -- Made Scientific, Inc., a leading U.S.-based clinical- and commercial-stage cell therapy contract development and...
Collaboration Supports ARPA-H-Funded Program to Develop Stem Cell Therapy Implants for Phase I Clinical Trial Under FDA Oversight PRINCETON, N.J., June 1, 2026 /PRNewswire/ -- Made Scientific, Inc., a leading U.S.-based clinical- and commercial-stage cell therapy contract development and...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.